Anti-NMDA receptor encephalitis: A cause of acute psychosis and catatonia

Journal of Psychiatric Practice

Volumn 19, Issue 2, 2013, Pages 157-161

  Ryan, Stephen A ^a   Costello, Daniel J ^a   Cassidy, Eugene M ^a   Brown, Gemma ^b   Harrington, Hugh J ^b   Markx, Sander ^c  

^a University College Cork and INFANT Centre   (Ireland)

^b MERCY UNIVERSITY HOSPITAL   (Ireland)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Anti N methyl D aspartate receptor (anti NMDAR) encephalitis; Catatonia; Dyskinesia; Ovarian teratoma; Psychiatric symptoms; Psychosis; Seizures

Indexed keywords

CYCLOPHOSPHAMIDE; HALOPERIDOL; IMMUNOGLOBULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLANZAPINE; RITUXIMAB; STEROID;

ACUTE PSYCHOSIS; ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANXIETY; ARTICLE; AUTISM; CASE REPORT; CATATONIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; LUMBAR PUNCTURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; OVARY TERATOMA; TRANSVAGINAL ECHOGRAPHY;

ADULT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOANTIBODIES; CATATONIA; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; OVARIAN NEOPLASMS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; TERATOMA; TREATMENT OUTCOME;

EID: 84878072534     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000428562.86705.cd     Document Type: Article

References (26)

1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8.
2. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology 2008;70:504-11.
3. Iizuka T, Sakai F. Anti-NMDA receptor encephalitis: Clinical manifestations and pathophysiology. Brain Nerve 2008;60:1047-60.
4. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-Daspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-8.
5. Dalmau J, Panzer J. Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol 2011;24: 346-53.
6. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133(Pt 6): 1655-67.
7. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-Nmethyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
8. Gabilondo I, Saiz A, Galán L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996-9.
9. Lancaster E, Dalmau J. Neuronal autoantigens-Pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012;8:380-90.
10. Lai M. Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-34.
11. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
12. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody. Neurology 2008;71:1291-2.
13. Lancaster E. Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 2011;77:1698-1701.
14. Dalmau J., Lancaster E., Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
15. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54:899-904.
16. Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012:79:1094-100.
17. Armangue T, Titulaer MJ, Málaga I, et al. Pediatric anti-Nmethyl-D-aspartate receptor encephalitis-Clinical analysis and novel findings in a series of 20 patients. J Pediatr 2012 Nov 16 [Epub ahead of print].
18. Tuzun E. Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-43.
19. Hansen HC, Klingbeil C, Dalmau J, et al. Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. Arch Neurol 2012 Oct 15:1-3. [Epub ahead of print].
20. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol 2013;12: 157-65
21. Gordon JA. Testing the glutamate hypothesis of schizophrenia. Nat Neurosci 2010;13:2-4.
22. Krystal JH, Anand A, Moghaddam B. Effects of NMDA receptor antagonism: Implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry 2002;59:663-4.
23. Belforte JE, Zsiros V, Sklar ER, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010;13: 76-83.
24. Barry H, Hardiman O, Healy DG, et al. Anti-NMDA receptor encephalitis: An important differential diagnosis in psychosis. Br J Psychiatry 2011;199:508-9.
25. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013 Jan 23:1-8 [Epub ahead of print].
26. Masdeu JC, González-Pinto A, Matute C, et al. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry 2012;169: 1120-1.